Page 31 - GPD-3-4

Gene & Protein in Disease GLUT5 in cancer development and therapy

Availability of data 11. Wuest M, Hamann I, Bouvet V, et al. Molecular imaging
of GLUT1 and GLUT5 in breast cancer: A multitracer
Not applicable. positron emission tomography imaging study in mice. Mol
Pharmacol. 2018;93:79-89.
References
doi: 10.1124/mol.117.110007
1. Song A, Mao Y, Wei H. GLUT5: Structure, functions,
diseases and potential applications. Acta Biochim Biophys 12. Su C, Li H, Gao W. GLUT5 increases fructose utilization and
Sin (Shanghai). 2023;55:1519-1538. promotes tumor progression in glioma. Biochem Biophy Res
Commun. 2018;500:462-469.
doi: 10.3724/abbs.2023158
doi: 10.1016/j.bbrc.2018.04.103
2. Shu R, David ES, Ferraris RP. Dietary fructose enhances
intestinal fructose transport and GLUT5 expression in 13. Carreño DV, Corro NB, Cerda-Infante NF, et al. Dietary
weaning rats. Am J Physiol Gastrointest Liver Physiol. fructose promotes prostate cancer growth. Cancer Res.
1997;272:G446-G453. 2021;81:2824-2832.
doi: 10.1152/ajpgi.1997.272.3.G446 doi: 10.1158/0008-5472.CAN-19-0456
3. Patel C, Douard V, Yu S, Gao N, Ferraris RP. Transport, 14. Suwannakul N, Armartmuntree N, Thanan R, et al. Targeting
metabolism, and endosomal trafficking-dependent fructose metabolism by glucose transporter 5 regulation in
regulation of intestinal fructose absorption. FASEB J. human cholangiocarcinoma. Genes Dis. 2022;9:1727-1741.
2015;29:4046-4058. doi: 10.1016/j.gendis.2021.09.002
doi: 10.1096/fj.15-272195 15. Weng Y, Fan X, Bai Y, et al. SLC2A5 promotes lung
4. Hannou SA, Haslam DE, McKeown NM, Herman MA. adenocarcinoma cell growth and metastasis by enhancing
Fructose metabolism and metabolic disease. J Clin Invest. fructose utilization. Cell Death Dis. 2018;4:38.
2018;128:545-555. doi: 10.1038/s41420-018-0038-5
doi: 10.1172/jci96702 16. Chen WL, Jin X, Wang M, et al. GLUT5-mediated fructose
5. Herman MA, Birnbaum MJ. Molecular aspects of utilization drives lung cancer growth by stimulating fatty
fructose metabolism and metabolic disease. Cell Metab. acid synthesis and AMPK/mTORC1 signaling. JCI Insight.
2021;33:2329-2354. 2020;5:e131596.
doi: 10.1016/j.cmet.2021.09.010 doi: 10.1172/jci.insight.131596
6. Elsaid S, Wu X, Tee SS. Fructose vs. glucose: Modulating stem 17. Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M,
cell growth and function through sugar supplementation. Lincet H. How the Warburg effect supports aggressiveness
FEBS Open Bio. 2024;14:1277-1290. and drug resistance of cancer cells? Drug Resist Updat.
2018;38:1-11.
doi: 10.1002/2211-5463.13846
doi: 10.1016/j.drup.2018.03.001
7. Krause N, Wegner A. Fructose metabolism in cancer. Cells.
2020;9:2635. 18. Douard V, Ferraris RP. The role of fructose transporters
in diseases linked to excessive fructose intake. J Physiol.
doi: 10.3390/cells9122635
2013;591:401-414.
8. Hadzi-Petrushev N, Stojchevski R, Jakimovska A, et al. doi: 10.1113/jphysiol.2011.215731
GLUT5-overexpression-related tumorigenic implications.
Mol Med. 2024;30:114. 19. Kannan S, Begoyan VV, Fedie JR, et al. Metabolism-driven
high-throughput cancer identification with GLUT5-specific
doi: 10.1186/s10020-024-00879-8
molecular probes. Biosensors (Basel). 2018;8:39.
9. Shen Z, Li Z, Liu Y, et al. GLUT5-KHK axis-mediated
fructose metabolism drives proliferation and chemotherapy doi: 10.3390/bios8020039
resistance of colorectal cancer. Cancer Lett. 2022;534:215617. 20. Szablewski L. Glucose transporters as markers of diagnosis
and prognosis in cancer diseases. Oncol Rev. 2022;16:561.
doi: 10.1016/j.canlet.2022.215617
doi: 10.4081/oncol.2022.561
10. Włodarczyk J, Włodarczyk M, Zielińska M, Jędrzejczak B,
Dziki L, Fichna J. Blockade of fructose transporter protein 21. RanaN, Aziz MA, Serya RAT, et al. A fluorescence-based
GLUT5 inhibits proliferation of colon cancer cells: Proof assay to probe inhibitory effect of fructose mimics on
of concept for a new class of anti-tumor therapeutics. GLUT5 transport in breast cancer cells. ACS Bio Med Chem
Pharmacol Rep. 2021;73:939-945. Au. 2023;3:51-61.
doi: 10.1007/s43440-021-00281-9 doi: 10.1021/acsbiomedchemau.2c00056

Volume 3 Issue 4 (2024) 10 doi: 10.36922/gpd.4171